Mogrify
Mogrify is a biotechnology company that develops proprietary tailored cell conversions that power every cell therapy.
Total raised
€38M
€37,629,959
Funding rounds
3
Investors
7
distinct backers
Active since
2019-10
latest 2023-10
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood28
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood19
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ €30M+ raised
- ▲ 10y since founding
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-10-03 | Series A | €9.5M | Ahren Innovation Capital,Astellas Venture Management,Dr Jonathan Milner,Parkwalk Advisors,Trend Investment Group | View deal → |
| 2021-05-04 | Series A | €14M | 24Haymarket,Astellas Venture Management,Dr Darrin M Disley,Dr Jonathan Milner,Parkwalk Advisors | View deal → |
| 2019-10-01 | Series A | €14M | Ahren Innovation Capital | View deal → |